Test Price
2,800 AED✅ Home Collection Available
RDH5 Gene Fundus Albipunctatus Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Summary
The RDH5 gene next‑generation sequencing (NGS) test provides precise molecular diagnosis of Fundus Albipunctatus, an autosomal recessive retinal dystrophy. The assay delivers >99.9% diagnostic sensitivity under ISO 9001:2015 accreditation, supported by temperature‑controlled home phlebotomy and telephonic clinical guidance.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑accredited processing.
- Premium Logistics: VIP mobile phlebotomy & temperature‑controlled cold‑chain home collection (daily 8 AM–11 PM).
- Clinical Guidance: Telephonic post‑test interpretation with a certified genetic counselor.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The RDH5 Gene NGS Test identifies pathogenic variants in the RDH5 gene, which encodes 11‑cis retinol dehydrogenase, an enzyme essential for the visual cycle. Biallelic mutations cause Fundus Albipunctatus, characterised by night blindness and pathognomonic white dots in the fundus. The test covers the full gene, including deep intronic regions, and is performed on whole blood, extracted DNA, or FTA card samples.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Precision / Sensitivity | >99.9% Diagnostic Sensitivity | ~95% Sensitivity |
| Methodology | Next‑Generation Sequencing (NGS) | Sanger Sequencing |
| Turnaround Time | 3 to 4 Weeks | 6 to 8 Weeks |
| Gene Coverage | Full gene including deep intronic regions | Limited exonic and flanking regions |
Physician Insight & Safety Protocols
“Understanding the genetic basis of a retinal condition can be life‑changing. This NGS test provides comprehensive analysis of the RDH5 gene, but it must be interpreted alongside clinical findings and a detailed family history. I recommend discussing results with your ophthalmologist and a certified genetic counselor.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory & Safety Exclusion
- Pre‑test counselling is strongly advised; the test should not replace a full ophthalmic examination including OCT and electroretinography.
- Exclusion criteria: Active ocular infection or inflammation, inability to provide informed consent (minors require guardian consent per UAE Federal Decree‑Law No. 4 of 2016 on Medical Liability), known bleeding disorder not managed by a physician.
- Emergency red flags – seek immediate ER care if you experience: Sudden severe vision loss, acute eye pain with redness and photophobia, flashes of light with new floaters (possible retinal detachment), or severe headache with vision changes.
⚠️ Do not discontinue any prescribed medication without consulting your doctor. Genetic test results do not replace clinical management.
Patient FAQ & Clinical Guidance
1. What is Fundus Albipunctatus and how does the RDH5 gene cause it?
Fundus Albipunctatus is an autosomal recessive retinal dystrophy caused by biallelic mutations in the RDH5 gene. The gene encodes 11‑cis retinol dehydrogenase, an enzyme that recycles visual pigment. Impaired function leads to delayed dark adaptation, night blindness, and accumulation of white dots across the retina.
2. How accurate is the NGS test for RDH5 mutations and what sample is needed?
The NGS test achieves over 99.9% diagnostic sensitivity. A single whole‑blood draw (or alternative sample: extracted DNA or FTA card) is sufficient for analysis. The test can be performed at our lab or via our secure mobile phlebotomy service.
3. Will my insurance cover this test and how do I arrange home collection?
Insurance coverage is confirmed through direct billing verification via WhatsApp at +971 54 548 8731. If eligible, a licensed phlebotomist will visit your home or office for sample collection between 8 AM and 11 PM, using temperature‑controlled cold‑chain logistics.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
This genetic testing service operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic counseling and consent procedures adhere to DHA and MOHAP standards. The laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | RDH5 Gene Fundus Albipunctatus Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD‑10‑CM Code | H35.59 (Other hereditary retinal dystrophy) |
| LOINC Code | 82455-4 (RDH5 gene sequence analysis) |
| DHA Facility License & Lab Address | Facility License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Laboratory: DNA Labs UAE. |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians